dc.contributor.author | Kashinkunti, Mohan D. | |
dc.contributor.author | Dhananjaya, M. | |
dc.date.accessioned | 2016-09-29T08:46:44Z | |
dc.date.available | 2016-09-29T08:46:44Z | |
dc.date.issued | 2013-12 | |
dc.identifier.citation | Medica Innovatica. 2013 Dec; 2(2): 118-120. | en_US |
dc.identifier.issn | 2278-7526 | |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/847 | |
dc.description.abstract | Ataxia-telangiectasia (AT) is a primary immunodeficiency disease with multisystem disorder characterized by progressive neurologic impairment, variable immunodeficiency, impaired organ maturation, oculo-cutaneous telangiectasia, and a predisposition to malignancy. It is a variable immunodeficiency involving both cellular and humoral responses and a predisposition to cancer. In 1995, a large gene was identified on chromosome 11q22-q23, known as AT Mutant(ATM) gene and the lack of its gene product, the ATM protein, is responsible for the clinical features of AT. Here we present a case of ataxia telangiectasia in a 16 year old female who presented with progressive ataxia. | en_US |
dc.language.iso | en | en_US |
dc.publisher | B.V.V. Sangha’s S. Nijalingappa Medical College | en_US |
dc.subject | Ataxia telangiectasia | en_US |
dc.subject | Humoral immunity | en_US |
dc.subject | Immunodeficiency | en_US |
dc.title | Ataxia telangiectasia case report from tertiary-care hospital of North Karnataka | en_US |
dc.type | Article | en_US |